Advances in Brain Tumor Surgery

Neurologic Clinics

Volumn 25, Issue 4, 2007, Pages 975-1003

  Asthagiri, Ashok R ^a   Pouratian, Nader ^b   Sherman, Jonathan ^b   Ahmed, Galal ^b   Shaffrey, Mark E ^b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CAMPTOTHECIN; CARBOPLATIN; CARMUSTINE; CINTREDEKIN BESUDOTOX; COTARA; CRM 107; DIPHTHERIA TOXIN; DOXORUBICIN; GEMCITABINE; INTERLEUKIN 13; MONOCLONAL ANTIBODY I 131; PACLITAXEL; POLYMER; PSEUDOMONAS EXOTOXIN; TOPOTECAN; TRANSFERRIN; UNCLASSIFIED DRUG;

BRACHYTHERAPY; BRAIN DEPTH STIMULATION; BRAIN MAPPING; BRAIN TUMOR; CANCER GRADING; CLINICAL TRIAL; DIFFUSION TENSOR IMAGING; EVOKED RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLIOMA; HUMAN; MAGNETOENCEPHALOGRAPHY; NEURONAVIGATION; PRIORITY JOURNAL; REVIEW;

BRACHYTHERAPY; BRAIN MAPPING; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; GLIOMA; HUMANS; INTRAOPERATIVE CARE; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; NEOPLASM STAGING; NEUROSURGICAL PROCEDURES; PREOPERATIVE CARE;

EID: 35349028239     PISSN: 07338619     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ncl.2007.07.006     Document Type: Review

References (136)

1. Winger M.J., Macdonald D.R., and Cairncross J.G. Supratentorial anaplastic gliomas in adults. The prognostic importance of extent of resection and prior low-grade glioma. J Neurosurg 71 4 (1989) 487-493
2. World Health Organization classification of tumors: pathology and genetics of tumours of nervous system. In: Kleihues P., and Cavenee W.K. (Eds) (2000), IARC Press, Lyon
3. CBTRUS. Statistical report: primary brain tumors in the United States, 1998-2002 (2005), Central Brain Tumor Registry of the United States, Hinsdale (IL)
4. Keles G.E., Lamborn K.R., and Berger M.S. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95 5 (2001) 735-745
5. Norden A.D., and Wen P.Y. Glioma therapy in adults. Neurologist 12 6 (2006) 279-292
6. Keles G.E., Aldape K., and Berger M.S. Low-grade gliomas: astrocytoma, oligodendroglioma and mixed gliomas. In: Winn H.R., and Youmans J.R. (Eds). Youmans neurological surgery. 5th edition (2004), Saunders, Philadelphia 950-968
7. Lunsford L.D., Somaza S., Kondziolka D., et al. Survival after stereotactic biopsy and irradiation of cerebral nonanaplastic, nonpilocytic astrocytoma. J Neurosurg 82 4 (1995) 523-529
8. Kondziolka D., and Lunsford L.D. The role of stereotactic biopsy in the management of gliomas. J Neurooncol 42 3 (1999) 205-213
9. Recht L.D., Lew R., and Smith T.W. Suspected low-grade glioma: is deferring treatment safe?. Ann Neurol 31 4 (1992) 431-436
10. Steiger H.J., Markwalder R.V., Seiler R.W., et al. Early prognosis of supratentorial grade 2 astrocytomas in adult patients after resection or stereotactic biopsy. An analysis of 50 cases operated on between 1984 and 1988. Acta Neurochir (Wien) 106 3-4 (1990) 99-105
11. Berger M.S., Deliganis A.V., Dobbins J., et al. The effect of extent of resection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer 74 6 (1994) 1784-1791
12. Ammirati M., Vick N., Liao Y.L., et al. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas. Neurosurgery 21 2 (1987) 201-206
13. Devaux B.C., O'Fallon J.R., and Kelly P.J. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome. J Neurosurg 78 5 (1993) 767-775
14. Lacroix M., Abi-Said D., Fourney D.R., et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95 2 (2001) 190-198
15. Nitta T., and Sato K. Prognostic implications of the extent of surgical resection in patients with intracranial malignant gliomas. Cancer 75 11 (1995) 2727-2731
16. Hess K.R. Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42 3 (1999) 227-231
17. Quigley M.R., and Maroon J.C. The relationship between survival and the extent of the resection in patients with supratentorial malignant gliomas. Neurosurgery 29 3 (1991) 385-388 [discussion: 388-9]
18. Nazzaro J.M., and Neuwelt E.A. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults. J Neurosurg 73 3 (1990) 331-344
19. Bulsara K.R., Johnson J., and Villavicencio A.T. Improvements in brain tumor surgery: the modern history of awake craniotomies. Neurosurg Focus 18 4 (2005) 1-3
20. Laws E.R., Parney I.F., Huang W., et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the glioma outcomes project. J Neurosurg 99 3 (2003) 467-473
21. Mineo J.F., Bordron A., Baroncini M., et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 149 3 (2007) 245-253
22. Scott J.N., Rewcastle N.B., Brasher P.M., et al. Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 25 3 (1998) 197-201
23. Vertosick Jr. F.T., and Selker R.G. Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. Surg Neurol 38 5 (1992) 359-363
24. Salcman M., Scholtz H., Kaplan R.S., et al. Long-term survival in patients with malignant astrocytoma. Neurosurgery 34 2 (1994) 213-219 [discussion: 219-20]
25. Chandler K.L., Prados M.D., Malec M., et al. Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32 5 (1993) 716-720 [discussion: 720]
26. Ciric I., Ammirati M., Vick N., et al. Supratentorial gliomas: surgical considerations and immediate postoperative results. Gross total resection versus partial resection. Neurosurgery 21 1 (1987) 21-26
27. Muhlbauer M., Gebhart E., Pfisterer W., et al. Microsurgery for glioblastoma preserves short-term quality of life both in functionally impaired and independent patients. Wien Klin Wochenschr 114 19-20 (2002) 866-873
28. Schiff D., and Shaffrey M.E. Role of resection for newly diagnosed malignant gliomas. Expert Rev Anticancer Ther 3 5 (2003) 621-630
29. Duffau H., Lopes M., Arthuis F., et al. Contribution of intraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry 76 6 (2005) 845-851
30. Reithmeier T., Krammer M., Gumprecht H., et al. Neuronavigation combined with electrophysiological monitoring for surgery of lesions in eloquent brain areas in 42 cases: a retrospective comparison of the neurological outcome and the quality of resection with a control group with similar lesions. Minim Invasive Neurosurg 46 2 (2003) 65-71
31. Wood C.C., Spencer D.D., Allison T., et al. Localization of human sensorimotor cortex during surgery by cortical surface recording of somatosensory evoked potentials. J Neurosurg 68 1 (1988) 99-111
32. Sutherling W.W., Crandall P.H., Darcey T.M., et al. The magnetic and electric fields agree with intracranial localizations of somatosensory cortex. Neurology 38 11 (1988) 1705-1714
33. Picht T., Kombos T., Gramm H.J., et al. Multimodal protocol for awake craniotomy in language cortex tumour surgery. Acta Neurochir (Wien) 148 2 (2006) 127-137
34. Huncke K., Van De Wiele B., Fried I., et al. The asleep-awake-asleep anesthetic technique for intraoperative language mapping. Neurosurgery 42 6 (1998) 1312-1316
35. Foerster O. The cerebral cortex of man. Lancet 109 (1931) 309-312
36. Penfield W., and Roberts L. Speech and brain mechanisms (1959), Princeton University, Princeton (NJ)
37. Haglund M.M., Berger M.S., Shamseldin M., et al. Cortical localization of temporal lobe language sites in patients with gliomas. Neurosurgery 34 4 (1994) 567-576 [discussion: 576]
38. Walker J.A., Quinones-Hinojosa A., and Berger M.S. Intraoperative speech mapping in 17 bilingual patients undergoing resection of a mass lesion. Neurosurgery 54 1 (2004) 113-117 [discussion: 118]
39. Roux F.E., Lubrano V., Lauwers-Cances V., et al. Intra-operative mapping of cortical areas involved in reading in mono- and bilingual patients. Brain 127 Pt 8 (2004) 1796-1810
40. Keles G.E., Lundin D.A., Lamborn K.R., et al. Intraoperative subcortical stimulation mapping for hemispherical perirolandic gliomas located within or adjacent to the descending motor pathways: evaluation of morbidity and assessment of functional outcome in 294 patients. J Neurosurg 100 3 (2004) 369-375
41. Duffau H., Capelle L., Sichez N., et al. Intraoperative mapping of the subcortical language pathways using direct stimulations. An anatomo-functional study. Brain 125 Pt 1 (2002) 199-214
42. Haglund M.M., Ojemann G.A., and Hochman D.W. Optical imaging of epileptiform and functional activity in human cerebral cortex. Nature 358 6388 (1992) 668-671
43. Toga A.W., Cannestra A.F., and Black K.L. The temporal/spatial evolution of optical signals in human cortex. Cerebral Cortex 5 6 (1995) 561-565
44. Cannestra A.F., Bookheimer S.Y., Pouratian N., et al. Temporal and topographical characterization of language cortices using intraoperative optical intrinsinc signals. Neuroimage 12 (2000) 41-54
45. Pouratian N., Bookheimer S.Y., O'Farrell A.M., et al. Optical imaging of bilingual cortical representations: case report. J Neurosurg 93 (2000) 686-691
46. Pouratian N, Martin NA, Cannestra AF, et al. Intraoperative sensorimotor and language mapping using optical intrinsic signal imaging: comparison with electrophysiologic techniques and fMRI in 40 patients. Paper presented at: 2000 American Association of neurological surgeons annual meeting. San Francisco, California, April 8-13, 2000.
47. Krings T., Topper R., Willmes K., et al. Activation in primary and secondary motor areas in patients with CNS neoplasms and weakness. Neurology 58 3 (2002) 381-390
48. Holodny A.I., Schulder M., Liu W.C., et al. The effect of brain tumors on BOLD functional MR imaging activation in the adjacent motor cortex: implications for image-guided neurosurgery. AJNR Am J Neuroradiol 21 (2000) 1415-1422
49. Schreiber A., Hubbe U., Ziyeh S., et al. The influence of gliomas and nonglial space-occupying lesions on blood-oxygen-level-dependent contrast enhancement. AJNR Am J Neuroradiol 21 (2000) 1055-1063
50. Schlosser R., Husche S., Gawehn J., et al. Characterization of BOLD-fMRI signal during a verbal fluency paradigm in patients with intracerebral tumors affecting the frontal lobe. Magn Reson Imaging 20 (2002) 7-16
51. Righini A., de Divitiis O., Prinster A., et al. Functional MRI: primary motor cortex localization in patients with brain tumors. J Comput Assist Tomogr 20 5 (1996) 702-708
52. Roux F.E., Boulanouar K., Lotterie J.A., et al. Language functional magnetic resonance imaging in preoperative assessment of language areas: correlation with direct cortical stimulation. Neurosurgery 52 6 (2003) 1335-1345 [discussion: 1345-7]
53. Nimsky C., Ganslandt O., Buchfelder M., et al. Intraoperative visualization for resection of gliomas: the role of functional neuronavigation and intraoperative 1.5 T MRI. Neurol Res 28 5 (2006) 482-487
54. Fox P.T., Mintun M.A., Raichle M.E., et al. Mapping human visual cortex with positron emission tomography. Nature 323 6091 (1986) 806-809
55. Belliveau J.W., Kennedy Jr. D.N., McKinstry R.C., et al. Functional mapping of the human visual cortex by magnetic resonance imaging. Science 254 5032 (1991) 716-719
56. Roessler K., Donat M., Lanzenberger R., et al. Evaluation of preoperative high magnetic field motor functional MRI (3 Tesla) in glioma patients by navigated electrocortical stimulation and postoperative outcome. J Neurol Neurosurg Psychiatry 76 8 (2005) 1152-1157
57. Kruger G., Kastrup A., and Glover G.H. Neuroimaging at 1.5 T and 3.0 T: comparison of oxygenation-sensitive magnetic resonance imaging. Magn Reson Med 45 4 (2001) 595-604
58. FitzGerald D.B., Cosgrove G.R., Ronner S., et al. Location of language in the cortex: a comparison between functional MR imaging and electrocortical stimulation. AJNR Am J Neuroradiol 18 (1997) 1529-1539
59. Pouratian N., Bookheimer S.Y., Rex D.E., et al. Utility of preoperative functional magnetic resonance imaging for identifying language cortices in patients with vascular malformations. J Neurosurg 97 1 (2002) 21-32
60. Mueller W.M., Yetkin F.Z., Hammeke T.A., et al. Functional magnetic resonance imaging mapping of the motor cortex in patients with cerebral tumors. Neurosurgery 39 3 (1996) 515-520 [discussion: 520-1]
61. Roux F.E., Boulanouar K., Ranjeva J.P., et al. Usefulness of motor functional MRI correlated to cortical mapping in Rolandic low-grade astrocytomas. Acta Neurochir (Wien) 141 1 (1999) 71-79
62. Lurito J.T., Lowe M.J., Sartorius C., et al. Comparison of fMRI and intraoperative direct cortical stimulation in localization of receptive language areas. J Comput Assist Tomogr 24 1 (2000) 99-105
63. Majos A., Tybor K., Stefanczyk L., et al. Cortical mapping by functional magnetic resonance imaging in patients with brain tumors. Eur Radiol 15 6 (2005) 1148-1158
64. Pouratian N., Sicotte N., Rex D., et al. Spatial/temporal correlation of BOLD and optical intrinsic signals in humans. Magn Reson Med 47 4 (2002) 766-776
65. Lehericy S., Duffau H., Cornu P., et al. Correspondence between functional magnetic resonance imaging somatotopy and individual brain anatomy of the central region: comparison with intraoperative stimulation in patients with brain tumors. J Neurosurg 92 4 (2000) 589-598
66. Makela J.P., Forss N., Jaaskelainen J., et al. Magnetoencephalography in neurosurgery. Neurosurgery 59 3 (2006) 493-510 [discussion: 510-1]
67. Schiffbauer H., Berger M.S., Ferrari P., et al. Preoperative magnetic source imaging for brain tumor surgery: a quantitative comparison with intraoperative sensory and motor mapping. J Neurosurg 97 6 (2002) 1333-1342
68. Gallen C.C., Schwartz B.J., Bucholz R.D., et al. Presurgical localization of functional cortex using magnetic source imaging. J Neurosurg 82 6 (1995) 988-994
69. Schiffbauer H., Ferrari P., Rowley H.A., et al. Functional activity within brain tumors: a magnetic source imaging study. Neurosurgery 49 6 (2001) 1313-1320 [discussion: 1320-1]
70. Ganslandt O., Buchfelder M., Hastreiter P., et al. Magnetic source imaging supports clinical decision making in glioma patients. Clin Neurol Neurosurg 107 1 (2004) 20-26
71. Grummich P., Nimsky C., Pauli E., et al. Combining fMRI and MEG increases the reliability of presurgical language localization: a clinical study on the difference between and congruence of both modalities. Neuroimage 32 4 (2006) 1793-1803
72. Korvenoja A., Kirveskari E., Aronen H.J., et al. Sensorimotor cortex localization: comparison of magnetoencephalography, functional MR imaging, and intraoperative cortical mapping. Radiology 241 1 (2006) 213-222
73. Berman J.I., Berger M.S., Mukherjee P., et al. Diffusion-tensor imaging-guided tracking of fibers of the pyramidal tract combined with intraoperative cortical stimulation mapping in patients with gliomas. J Neurosurg 101 1 (2004) 66-72
74. Kamada K., Todo T., Masutani Y., et al. Visualization of the frontotemporal language fibers by tractography combined with functional magnetic resonance imaging and magnetoencephalography. J Neurosurg 106 1 (2007) 90-98
75. Spiegel E., Wycis H., Marks M., et al. Stereotaxic apparatus for operations on the human brain. Science 106 (1947) 349-350
76. Roberts D.W., Strohbehn J.W., Hatch J.F., et al. A frameless stereotaxic integration of computerized tomographic imaging and the operating microscope. J Neurosurg 65 4 (1986) 545-549
77. McDermott M. Intracranial gliomas. In: Barnett G.H., Roberts D.W., and Maciunas R.J. (Eds). Image-guided neurosurgery: clinical applications of surgical navigation (1998), Quality Medical Pub., St. Louis (MO) 77-86
78. Meyer F.B., Bates L.M., Goerss S.J., et al. Awake craniotomy for aggressive resection of primary gliomas located in eloquent brain. Mayo Clin Proc 76 7 (2001) 677-687
79. Stapleton S.R., Kiriakopoulos E., Mikulis D., et al. Combined utility of functional MRI, cortical mapping, and frameless stereotaxy in the resection of lesions in eloquent areas of brain in children. Pediatr Neurosurg 26 2 (1997) 68-82
80. Lumenta C.B., Gumprecht H.K., Leonardi M.A., et al. Three-dimensional computer-assisted stereotactic-guided microneurosurgery combined with cortical mapping of the motor area by direct electrostimulation. Minim Invasive Neurosurg 40 2 (1997) 50-54
81. Maurer Jr. C.R., Hill D.L., Martin A.J., et al. Investigation of intraoperative brain deformation using a 1.5-T interventional MR system: preliminary results. Ieee Transactions on Medical Imaging 17 5 (1998) 817-825
82. Nimsky C., Ganslandt O., Hastreiter P., et al. Intraoperative compensation for brain shift. Surg Neurol 56 6 (2001) 357-364 [discussion: 364-5]
83. Nabavi A., Black P.M., Gering D.T., et al. Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 48 4 (2001) 787-797 [discussion: 797-8]
84. Albayrak B., Samdani A.F., and Black P.M. Intra-operative magnetic resonance imaging in neurosurgery. Acta Neurochir (Wien) 146 6 (2004) 543-556 [discussion: 557]
85. Fahlbusch R., Ganslandt O., Buchfelder M., et al. Intraoperative magnetic resonance imaging during transsphenoidal surgery. J Neurosurg 95 3 (2001) 381-390
86. Truwit C.L., and Hall W.A. Intraoperative magnetic resonance imaging-guided neurosurgery at 3-T. Neurosurgery 58 4 Suppl 2 (Apr 2006) ONS-338-345 [discussion: ONS-345-6]
87. Tummala R.P., Chu R.M., Liu H., et al. Optimizing brain tumor resection. High-field interventional MR imaging. Neuroimaging Clin N Am 11 4 (2001) 673-683
88. Lewin J.S., Metzger A., and Selman W.R. Intraoperative magnetic resonance image guidance in neurosurgery. J Magn Reson Imaging 12 4 (2000) 512-524
89. Sutherland G.R., Kaibara T., Louw D., et al. A mobile high-field magnetic resonance system for neurosurgery. J Neurosurg 91 5 (1999) 804-813
90. Hall W.A., Liu H., Maxwell R.E., et al. Influence of 1.5-Tesla intraoperative MR imaging on surgical decision making. Acta Neurochir 85 Suppl (2003) 29-37
91. McPherson C.M., Bohinski R.J., Dagnew E., et al. Tumor resection in a shared-resource magnetic resonance operating room: experience at the University of Cincinnati. Acta Neurochir 85 Suppl (2003) 39-44
92. Jolesz F.A., and Blumenfeld S.M. Interventional use of magnetic resonance imaging. Magn Reson Q 10 2 (1994) 85-96
93. Black P.M., Moriarty T., Alexander III E., et al. Development and implementation of intraoperative magnetic resonance imaging and its neurosurgical applications. Neurosurgery 41 4 (1997) 831-842 [discussion: 842-5]
94. Lipson A.C., Gargollo P.C., and Black P.M. Intraoperative magnetic resonance imaging: considerations for the operating room of the future. J Clin Neurosci 8 4 (2001) 305-310
95. Kanner A.A., Vogelbaum M.A., Mayberg M.R., et al. Intracranial navigation by using low-field intraoperative magnetic resonance imaging: preliminary experience. J Neurosurg 97 5 (2002) 1115-1124
96. Schulder M., Sernas T.J., and Carmel P.W. Cranial surgery and navigation with a compact intraoperative MRI system. Acta Neurochir 85 Suppl (2003) 79-86
97. Black P.M., Alexander III E., Martin C., et al. Craniotomy for tumor treatment in an intraoperative magnetic resonance imaging unit. Neurosurgery 45 3 (1999) 423-431 [discussion: 431-3]
98. Wirtz C.R., Knauth M., Staubert A., et al. Clinical evaluation and follow-up results for intraoperative magnetic resonance imaging in neurosurgery. Neurosurgery 46 5 (2000) 1112-1120 [discussion: 1120-2]
99. Lawson H.C., Sampath P., Bohan E., et al. Interstitial chemotherapy for malignant gliomas: the Johns Hopkins experience. J Neurooncol 83 1 (2006) 61-67
100. Wang C.C., Li J., Teo C.S., et al. The delivery of BCNU to brain tumors. J Control Release 61 1-2 (1999) 21-41
101. Blasberg R.G., Patlak C., and Fenstermacher J.D. Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195 1 (1975) 73-83
102. Tamargo R.J., Epstein J.I., Reinhard C.S., et al. Brain biocompatibility of a biodegradable, controlled-release polymer in rats. J Biomed Mater Res 23 2 (1989) 253-266
103. Tamargo R.J., Myseros J.S., Epstein J.I., et al. Interstitial chemotherapy of the 9L gliosarcoma: controlled release polymers for drug delivery in the brain. Cancer Res 53 2 (1993) 329-333
104. Yang M.B., Tamargo R.J., and Brem H. Controlled delivery of 1,3-bis (2-chloroethyl)-1-nitrosourea from ethylene-vinyl acetate copolymer. Cancer Res 49 18 (1989) 5103-5107
105. Brem H., Mahaley Jr. M.S., Vick N.A., et al. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74 3 (1991) 441-446
106. Brem H., Piantadosi S., Burger P.C., et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain tumor treatment group. Lancet 345 8956 (1995) 1008-1012
107. Valtonen S., Timonen U., Toivanen P., et al. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41 1 (1997) 44-48 [discussion: 48-9]
108. Westphal M., Hilt D.C., Bortey E., et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neurooncol 5 2 (2003) 79-88
109. Sipos E.P., Tyler B., Piantadosi S., et al. Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors. Cancer Chemother Pharmacol 39 5 (1997) 383-389
110. Olivi A., Ewend M.G., Utsuki T., et al. Interstitial delivery of carboplatin via biodegradable polymers is effective against experimental glioma in the rat. Cancer Chemother Pharmacol 39 1-2 (1996) 90-96
111. Walter K.A., Cahan M.A., Gur A., et al. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res 54 8 (1994) 2207-2212
112. Weingart J.D., Thompson R.C., Tyler B., et al. Local delivery of the topoisomerase I inhibitor camptothecin sodium prolongs survival in the rat intracranial 9L gliosarcoma model. Int J Cancer 62 5 (1995) 605-609
113. Judy K.D., Olivi A., Buahin K.G., et al. Effectiveness of controlled release of a cyclophosphamide derivative with polymers against rat gliomas. J Neurosurg 82 3 (1995) 481-486
114. Weingart J.D., Sipos E.P., and Brem H. The role of minocycline in the treatment of intracranial 9L glioma. J Neurosurg 82 4 (1995) 635-640
115. Williams J.A., Dillehay L.E., Tabassi K., et al. Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma. J Neurooncol 32 3 (1997) 181-192
116. Wiranowska M., Ransohoff J., Weingart J.D., et al. Interferon-containing controlled-release polymers for localized cerebral immunotherapy. J Interferon Cytokine Res 18 6 (1998) 377-385
117. Rhines L.D., Sampath P., Dolan M.E., et al. O6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat glioma. Cancer Res 60 22 (2000) 6307-6310
118. Sampath P., Hanes J., DiMeco F., et al. Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. Cancer Res 59 9 (1999) 2107-2114
119. Nguyen T.T., Pannu Y.S., Sung C., et al. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg 98 3 (2003) 584-590
120. Bobo R.H., Laske D.W., Akbasak A., et al. Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A 91 6 (1994) 2076-2080
121. Croteau D., Walbridge S., Morrison P.F., et al. Real-time in vivo imaging of the convective distribution of a low-molecular-weight tracer. J Neurosurg 102 1 (2005) 90-97
122. Krauze M.T., Saito R., Noble C., et al. Reflux-free cannula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 103 5 (2005) 923-929
123. Lidar Z., Mardor Y., Jonas T., et al. Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg 100 3 (2004) 472-479
124. Degen J.W., Walbridge S., Vortmeyer A.O., et al. Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg 99 5 (2003) 893-898
125. Yamashita Y., Krauze M.T., Kawaguchi T., et al. Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenografts. Neurooncol 9 1 (2007) 20-28
126. Weber F., Asher A., Bucholz R., et al. Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma. J Neurooncol 64 1-2 (2003) 125-137
127. Rainov N.G., and Heidecke V. Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001). J Neurooncol 66 1-2 (2004) 197-201
128. Rand R.W., Kreitman R.J., Patronas N., et al. Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin Cancer Res 6 6 (2000) 2157-2165
129. Kunwar S., Prados M.D., Chang S.M., et al. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol 25 7 (2007) 837-844
130. Vandergrift W.A., Patel S.J., Nicholas J.S., et al. Convection-enhanced delivery of immunotoxins and radioisotopes for treatment of malignant gliomas. Neurosurg Focus 20 4 (2006) 1-8
131. Patel S.J., Shapiro W.R., Laske D.W., et al. Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery 56 6 (2005) 1243-1252 [discussion: 1252-3]
132. Walker M.D., Green S.B., Byar D.P., et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 303 23 (1980) 1323-1329
133. Tatter S.B., Shaw E.G., Rosenblum M.L., et al. An inflatable balloon catheter and liquid 125I radiation source (GliaSite radiation therapy system) for treatment of recurrent malignant glioma: multicenter safety and feasibility trial. J Neurosurg 99 2 (2003) 297-303
134. Chan T.A., Weingart J.D., Parisi M., et al. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Int J Radiat Oncol Biol Phys 62 4 (2005) 1133-1139
135. Gabayan A.J., Green S.B., Sanan A., et al. GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery 58 4 (2006) 701-709 [discussion: 701-9]
136. Welsh J., Sanan A., Gabayan A.J., et al. GLIASite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study. Int J Radiat Oncol Biol Phys 68 1 (2007) 159-165